A Multi-Disciplinary Center Developing New Tools and Therapeutics
7th annual UCDDC Symposium AGENDA
2025 UCDDC Symposium at UC Riverside
School of Medicine Education II Building , room 205
Wednesday, May 21, 2025 - 9 am-5 pm
(subject to change)
| 9-9:20 am | Registration, Posters, Light refreshments. |
| 9:30-9:40 am |
Welcome and Introduction to the SymposiumMaurizio Pellecchia, PhD, UC Riverside Rodolfo Torres, PhD, VC Research & Economic Development, UC Riverside |
| 9:40-9:50 am | UC Drug Discovery Consortium: introduction and announcements Michael A. Rogawski, PhD, UC Davis |
Session I chair: Melanie Cocco, UC Irvine |
|
| 9:50-10:15 am | “Spatial Mapping of Organelle Networks and Metabolism in Lung Cancer” David Shackelford, PhD, UC Los Angeles |
| 10:15-10:40 am | “The development of targeted epigenetic editors for the treatment of genetic epilepsy” Kyle Fink, PhD, UC Davis |
| 10:40-11:05 am | “Discovery of antiviral leads with superior efficacy in SARS-CoV2 and MERS infection models" Adam Renslo, PhD, UC San Francisco |
| 11:05-11:30 am | “Massively parallel, single-molecule assessment of synthetic fidelity and drug-like properties in a DNA-encoded library” Scott Lokey, PhD, UC Santa Cruz |
| 11:30am-1:30 pm |
Lunch and poster presentations(optional walks to either the botanical gardens or to the MRB1 incubator laboratory space) |
Session II chairs: UCDDC ECUC Translates round table session: From academic research to spin-off biotech companies |
|
| 1:30-1:35 pm | Amplyx Pharmaceuticals, UC San Francisco spin-off Jason Gestwicki, PhD, Co-founder |
| 1:35-1:40 pm | Eicosis, UC Davis spin-off Cindy McReynolds, PhD, CEO |
| 1:40-1:45 pm | Zenith Therapeutics, UC Berkeley spin-off Julia Schaletzky, PhD, Co-founder |
| 1:45-1:50 pm | Armida Labs, UC Riverside spin-off
Carlo Baggio, PhD., Co-founder and CTO |
| 1:50-1:55 pm | Unnatural products - UC Santa Cruz spin-off Cameron Pye, PhD., Co-founder and CSO Josh Schwochert, PhD., Co-founder and CTO |
| 1:55-2:00 pm | Ocean Therapeutics - UC San Diego spin-off William Fenical, Ph.D., Founder |
| 2:00-2:05 pm | HomeLab - UC wide accelerator (UCSD)
Julio de Unamuno IV, Executive Director |
| 2:05-2:35 pm | UC spin-off panel/round table discussion |
| 2:35-3:00 pm | Afternoon Break and Poster presentations |
Session III chair: Robert Damoiseaux, PhD. UC Los Angeles |
|
| 3:00-3 :20pm | “The ESCRT system of membrane remodeling as a new target for drug discovery” Jim Hurley, PhD., UC Berkeley |
| 3:20-3:45pm | “Drugs Designed to Treat Sickle Cell Disease: Mechanisms of Binding to Hemoglobin” Melanie Cocco, PhD., UC Irvine |
| 3:45-4:10pm | “Covalent drug discovery targeting His/Lys or Tyr residues” Maurizio Pellecchia, PhD., UC Riverside |
| 4:10-4:15pm | Poster Awards Maurizio Pellecchia, PhD and the UCDDC EC |
Keynote Presentation Chair, Michael Gilson UC San Diego |
|
| 4:15-5pm | “Angiogenesis: Basic Biology and Therapeutic Opportunities” Keynote speaker, Napoleone Ferrara, MD., UC San Diego |
| 5-5:30pm | Light refreshments and adjourn |